Literature DB >> 2170613

Acute hemodynamic effects of converting enzyme inhibition in infants with congestive heart failure.

K S Rheuban1, M A Carpenter, C A Ayers, H P Gutgesell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2170613     DOI： 10.1016/s0022-3476(05)80712-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  6 in total

1.  Afterload reduction by hydralazine in children with a ventricular septal defect as determined by aortic input impedance.

Authors:  H Endo; H Shiraishi; M Yanagisawa
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

Review 2.  ACE inhibitors in pediatric patients with heart failure.

Authors:  Kazuo Momma
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

3.  Efficacy and dosage of enalapril in congenital and acquired heart disease.

Authors:  A M Leversha; N J Wilson; P M Clarkson; A L Calder; M C Ramage; J M Neutze
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

4.  Inhibition of angiotensin converting enzyme with enalapril maleate in infants with congestive heart failure.

Authors:  J P Dutertre; E M Billaud; E Autret; A Chantepie; I Oliver; J Laugier
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335

5.  Audit of therapeutic interventions in inpatient children using two scores: are they evidence-based in developing countries?

Authors:  Nilton Y Carreazo; Carlos A Bada; Juan P Chalco; Luis Huicho
Journal:  BMC Health Serv Res       Date:  2004-12-29       Impact factor: 2.655

Review 6.  Evaluation and treatment of hypertensive crises in children.

Authors:  Deborah R Stein; Michael A Ferguson
Journal:  Integr Blood Press Control       Date:  2016-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.